Edges in Network
| Network | GSE25065_top500tf - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | HAND1 |
| Upstream (Parents) |
|---|
| (<<) NFE2 → HAND1 |
| (<<) TAL1 → HAND1 |
| (<<) NPAT → HAND1 |
| (<<) GTF2I → HAND1 |
| (<<) ENO1 → HAND1 |
| (<<) IRF2 → HAND1 |
| Downstream (Children) |
|---|
| HAND1 → ZNF165 (>>) |
| HAND1 → SLC26A3 (>>) |
| HAND1 → TBX1 (>>) |
| HAND1 → TP53 (>>) |
| HAND1 → NPAS2 (>>) |
| HAND1 → SUPT6H (>>) |
| HAND1 → NFAT5 (>>) |
| HAND1 → NFYA (>>) |
| HAND1 → JUN (>>) |
| HAND1 → STAT1 (>>) |
| HAND1 → ST18 (>>) |
| HAND1 → ZNF45 (>>) |
| HAND1 → TADA3 (>>) |
| HAND1 → GABPB1 (>>) |
| HAND1 → SMAD1 (>>) |
| HAND1 → ZFHX3 (>>) |
| HAND1 → ZNF155 (>>) |
| HAND1 → ZNF81 (>>) |
| HAND1 → SALL1 (>>) |
| HAND1 → EGR4 (>>) |
| HAND1 → TCF3 (>>) |
| HAND1 → FOXC2 (>>) |
| HAND1 → TCF12 (>>) |
| HAND1 → RARA (>>) |
| HAND1 → MGA (>>) |
| HAND1 → PRDM2 (>>) |
| HAND1 → NFYB (>>) |
| HAND1 → E2F6 (>>) |
| HAND1 → HNF4G (>>) |
| HAND1 → NFYC (>>) |
| HAND1 → TP63 (>>) |
| HAND1 → GABPA (>>) |
| HAND1 → NFATC3 (>>) |
| HAND1 → HNF1B (>>) |
| HAND1 → NEUROG1 (>>) |
| HAND1 → PPBPL2 (>>) |
| HAND1 → RUNX2 (>>) |
| HAND1 → NFE2L1 (>>) |
| HAND1 → ELF2 (>>) |
| HAND1 → ATF5 (>>) |
| HAND1 → ISL1 (>>) |
| HAND1 → TFAM (>>) |
| HAND1 → GLI2 (>>) |
| HAND1 → ESRRA (>>) |
| HAND1 → TFCP2 (>>) |
| HAND1 → CEBPE (>>) |
| HAND1 → CTBP1 (>>) |
| HAND1 → ADNP2 (>>) |
| HAND1 → USF2 (>>) |
| HAND1 → PHOX2B (>>) |
| HAND1 → POU3F4 (>>) |
| HAND1 → FOXF1 (>>) |
| HAND1 → MYOD1 (>>) |
| HAND1 → HIC1 (>>) |
| HAND1 → KLF1 (>>) |
| HAND1 → HOXB8 (>>) |
